Doctor Boras graduated from the Faculty of Medicine of the University of Zagreb in 2007. Upon completion of one-year internship in Clinical Hospital Sestre Milosrdnice, he starts specialization in ophthalmology in 2008, under the mentorship of Professor Nikica Gabrić, PhD He passed specialist exam in 2013.
The main fields of interest of Doctor Boras are posterior ocular segment diseases, i.e., retina diseases. Daily activities include diagnostic and therapeutic procedures in patients suffering from various diseases of posterior part of the eye, such as macula degeneration, diabetic retinopathy and others.
In his work he uses the most modern diagnostic tools as swept source OCT, fluorescein angiography, fundus autofluorescence. In the treatment of retina diseases he uses the most modern medicaments such as intravitreal injection of anti-VEGF group of medicaments, and for the treatment of diabetic retinopathy and retinal rupture he uses the most modern Pascal laser.
Membership in associations
Croatian Society of Cataract and Refractive Surgery (CSCRS)
European Society of Cataract and Refractive Surgery (ESCRS)
Publications and research
He participates in the international multicenter study as a part of the team of clinic Svjetlost that explores intravitreal drug Fovista in the treatment of wet macular degeneration.
Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant; Latic R., Lukic M., Boras I.; Draca N., Vlasic M.; Gabric N.; Tomic Z.; Retina 2013; Aug 22.
Anti-VEGF in treatment of diabetic macular edema; Boras I.; Lazic R.; Gabric N.; Lukic M.; Dekaris I.; Collegium Antropologicum ; Vol. 35- supplement 2 No.2 9/2011.
I. Boras, M. Vlašić, N. Gabrić, R. Lazić: Verteporfin Photodynamic Theraphy Combined With Intravitreal Ranibizumab for Idiopathic Choroidal Neovascular Membrane. Dubrovnik Ophthalmology Academy, 2009.
I. Boras, M. Vlašić, N. Gabrić, R. Lazić: Verteporfin Photodynamic Theraphy Combined With Intravitreal Ranibizumab for Idiopathic Choroidal Neovascular Membrane. 6th Congress of South-East European Ophthalmological Society (SEEOS), June 2009.